IIM
TEVA icon

INTECH Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

INTECH Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Sell
474,709
-4,230
-0.9% -$141K 0.15% 113
2026
Q1 		$14.4M Buy
478,939
+78,831
+20% +$2.54M 0.14% 120
2025
Q4 		$12.5M Sell
400,108
-42,229
-10% -$1.04M 0.11% 151
2025
Q3 		$8.94M Buy
442,337
+91,938
+26% +$1.61M 0.08% 219
2025
Q2 		$5.87M Buy
350,399
+1,059
+0.3% +$17.1K 0.06% 308
2025
Q1 		$5.37M Buy
349,340
+106,108
+44% +$1.9M 0.06% 303
2024
Q4 		$5.36M Buy
243,232
+218,850
+898% +$3.98M 0.05% 309
2024
Q3 		$439K Buy
+24,382
New +$427K ﹤0.01% 1301
2023
Q4 		– Sell
-15,239
Closed -$155K – 749
2023
Q3 		$155K Sell
15,239
-2,065
-12% -$19.2K ﹤0.01% 701
2023
Q2 		$130K Sell
17,304
-82,352
-83% -$668K ﹤0.01% 702
2023
Q1 		$882K Sell
99,656
-10,127
-9% -$100K 0.01% 538
2022
Q4 		$1M Hold
109,783
– – 0.01% 522
2022
Q3 		$886K Sell
109,783
-5,018
-4% -$44.4K 0.01% 522
2022
Q2 		$863K Buy
+114,801
New +$1M 0.01% 543

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

INTECH Investment Management's TEVA Position: Q2 2026 in Review

INTECH Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 0.88% in Q2 2026, selling an estimated $141K and leaving 474,709 shares worth $16.1M. The position accounts for 0.15% of the portfolio, ranked #113.

INTECH Investment Management first reported a position in TEVA in Q2 2022 and has held it in 14 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • INTECH Investment Management held 474,709 shares of Teva Pharmaceuticals worth $16.1M as of Q2 2026.
  • INTECH Investment Management sold 4,230 Teva Pharmaceuticals shares in Q2 2026, an estimated $141K.
  • Teva Pharmaceuticals made up 0.15% of INTECH Investment Management's portfolio in Q2 2026, its #113 holding.
  • INTECH Investment Management first reported a position in Teva Pharmaceuticals in Q2 2022 and has held it in 14 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.